Outset Medical, Inc. (OM) stock
OMNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3071% below fair value
$3.86−0.31 (-7.43%)
Close on Nov 12, 2026Market cap $72.56MP/E –Yield –
Outset Medical cash
Cash and short-term investments held at the end of each period.
Outset Medical's cash was $136.63M at Sep 30, 2026. For fiscal 2025 it was $168.95M, up 6.5% from the year before. The highest annual figure on record is $339.50M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $168.95M | +6.5% |
| FY2024 | Dec 31, 2024 | $158.69M | -22.0% |
| FY2023 | Dec 31, 2023 | $203.32M | -29.3% |
| FY2022 | Dec 31, 2022 | $287.50M | -15.3% |
| FY2021 | Dec 31, 2021 | $339.50M | +7.8% |
| FY2020 | Dec 31, 2020 | $314.90M | +349.4% |
| FY2019 | Dec 31, 2019 | $70.08M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $136.63M | -23.5% |
| Q2 FY2026 | Jun 30, 2026 | $147.19M | -20.0% |
| Q1 FY2026 | Mar 31, 2026 | $156.71M | -17.1% |
| Q4 FY2025 | Dec 31, 2025 | $168.95M | +6.5% |
| Q3 FY2025 | Sep 30, 2025 | $178.64M | +1.7% |
| Q2 FY2025 | Jun 30, 2025 | $184.09M | -5.5% |
| Q1 FY2025 | Mar 31, 2025 | $189.00M | -16.7% |
| Q4 FY2024 | Dec 31, 2024 | $158.69M | -22.0% |
| Q3 FY2024 | Sep 30, 2024 | $175.63M | -9.5% |
| Q2 FY2024 | Jun 30, 2024 | $194.85M | -12.5% |
| Q1 FY2024 | Mar 31, 2024 | $226.92M | -8.9% |
| Q4 FY2023 | Dec 31, 2023 | $203.32M | -29.3% |
| Q3 FY2023 | Sep 30, 2023 | $194.00M | -14.7% |
| Q2 FY2023 | Jun 30, 2023 | $222.80M | -15.0% |
| Q1 FY2023 | Mar 31, 2023 | $249.20M | -17.6% |
| Q4 FY2022 | Dec 31, 2022 | $287.50M | -15.3% |
| Q3 FY2022 | Sep 30, 2022 | $227.50M | -39.0% |
| Q2 FY2022 | Jun 30, 2022 | $262.10M | -33.8% |
| Q1 FY2022 | Mar 31, 2022 | $302.30M | +8.9% |
| Q4 FY2021 | Dec 31, 2021 | $339.50M | +7.8% |
| Q3 FY2021 | Sep 30, 2021 | $373.00M | +8.4% |
| Q2 FY2021 | Jun 30, 2021 | $396.20M | +179.3% |
| Q1 FY2021 | Mar 31, 2021 | $277.50M | +75.7% |
| Q4 FY2020 | Dec 31, 2020 | $314.90M | +349.4% |
| Q3 FY2020 | Sep 30, 2020 | $344.20M | +777.7% |
| Q2 FY2020 | Jun 30, 2020 | $141.87M | – |
| Q1 FY2020 | Mar 31, 2020 | $157.96M | – |
| Q4 FY2019 | Dec 31, 2019 | $70.08M | – |
| Q3 FY2019 | Sep 30, 2019 | $39.22M | – |
See a number that looks wrong?